Breast Imaging Technologies Market Analysis | 2022-2028

Market Insights

The Breast Imaging Technologies Market was estimated at US$ 3.93 billion in 2021 and is expected to grow at a CAGR of 9.3% during 2022-2028 to reach US$ 8.39 billion in 2028.

Wish to get a free sample? Register Here

What is Breast Imaging Technology?

A form of medical technology called breast imaging is used to find or diagnose breast cancer in female patients. Breast imaging technology helps to diagnose numerous breast-related illnesses by providing radiological images of women's breasts. Breast imaging techniques include nuclear imaging, mammography, breast ultrasonography, and magnetic resonance imaging (MRI). This test's primary objective is to identify breast cancer and other conditions related to the breast as early as possible, while they are still curable.

Market Dynamics

Breast imaging assists in the diagnosis of breast cancer and other related issues, therefore as the incidence of breast cancer rises, the market is anticipated to expand significantly. Additionally, a significant factor impacting the growth rate of the breast imaging market will be the rise in government campaigns to educate the public about the need for early breast cancer identification. The development of breast imaging modalities is a crucial additional element driving the market's growth. Additionally, the growing elderly population and the degree of public-private funding, grants, and investments are the main factors boosting market expansion.

For the early detection of breast cancer, breast imaging is essential. Nevertheless, ionizing radiation is used for diagnosis in a few breast imaging techniques. Digital mammography (DM), digital breast tomosynthesis (DBT), contrast-enhanced mammography (CEM), whole-breast computed tomography (WBCT), breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), and positron emission mammography are all potential new breast screening techniques that use ionizing radiation (PEM). Consequently, increasing radiation exposure risk will provide new challenges for the breast imaging business. On the other side, the market's expansion will be hampered by the high cost of imaging systems or technologies. The market for breast imaging will also face significant difficulties due to the unfavorable reimbursement situation in developing and underdeveloped nations. Nevertheless, the introduction of unfavorable conditions as a result of the COVID-19 outbreak and stringent regulatory approval procedures hampers the market growth. 

Covid-19 Impact

The Covid-19 pandemic had a detrimental effect on several global markets. Additionally, it had a substantial influence on breast imaging treatments. Market demand has been hampered by lockdowns and other restrictions imposed by governments all over the world. To stop the virus from spreading, governments have also put regulations in place that postpone elective and non-urgent medical procedures. Additionally, a significant decrease in breast imaging diagnoses was caused by the virus's fear of transmission, particularly during COVID-19's first wave in 2020. Breast Cancer Now (UK) data from September 2020 claims that COVID-19 has resulted in over 9,86,000 women in the UK skipping their breast screening visits. Compared to data from 2019, there was a 64 percent fall in mammography, a 47.7% decline in breast ultrasound, and a 41.7% decline in breast MRI cases in Turkey, according to research published in the Eurasian Journal of Medical Investigation in 2020. Thus, COVID-19 had a significant negative impact on the breast imaging technology industry.

Segments Analysis

By Technology Type

The market is further segmented into ionizing breast imaging technology and non-ionizing breast imaging technology. The ionizing segment is further segmented into analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/ computed tomography (PET/CT), molecular breast imaging/ breast specific gamma imaging (MBI/BSMI), positron emission mammography, and others. The non-ionizing segment is divided into breast MRI, breast ultrasound, optical imaging, automated whole breast ultrasound (AWBU), breast thermography, and others.

By End-User Type

The market is further segmented into hospitals, diagnostic laboratories, ambulatory surgical centers, and others.

Regional Analysis

The breast imaging technologies market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Due to the increasing implementation of cutting-edge healthcare imaging technologies and the presence of significant market participants in this region, North America dominates the breast imaging market. The rising incidence of breast cancer will also accelerate the market's growth rate in this area

Want to know which region offers the best growth opportunities? Register Here

Key Players

The following are the major players in the breast imaging technologies market:

• Allengers
• Aurora Healthcare US Corp.
• Canon Inc.
• Carestream Health
• CMR Naviscan
• Cura Healthcare
• Delphinus Medical Technologies, Inc.
• Dilon Technologies, Inc.
• Fujifilm Holdings Corporation
• GE Healthcare (General Electric Company)
• Hologic, Inc.
• Koninklijke Philips N.V.
• Kub Technologies
• Micrima Limited
• NP JSC Amico
• Planmed OY
• QT Ultrasound LLC
• Siemens Healthcare
• Sonociné
• Supersonic Imagine

The overall competitive landscape has been affected due to many key factors. 

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s breast imaging technologies market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

Recent Developments

The market is established by the presence of both domestic and foreign businesses. To grow their market share globally, enter emerging markets, and establish their brands, these market players are anticipated to concentrate on several expansion strategies. These players prioritize making improvements to their services to increase revenue significantly and draw in a larger customer base. The introduction of novel products, mergers, and acquisitions, agreements or partnerships, and the expansion of company networks are further growth-stimulating factors shortly for the global market. For instance:

• In November 2020, the first artificial intelligence-powered telehealth technologist training platform was made available by Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, in partnership with Mammography Educators. This platform supports business continuity in mammography facilities. Densitas and Mammography Educators have teamed up to offer specialized educational materials and a telemedicine service that offers live virtual training based on Densitas IntelliMammo technician evaluations. By providing quantitative image quality metrics at the technician and mammography facility levels, the densities intelliMammo suite enables the detection of trends in technologists' performance, allowing mammography educators to create an evidence-based curriculum that is tailored for mammography practices.
• In October 2020, the commercial availability of Hologic, Inc.'s 3DQuorum Imaging Technology, Powered by Genius AI in Europe was announced. The invention is crucial as clinics try to handle the backlog of women whose normal breast screening was postponed due to the COVID-19 lockout. It was created to aid increase mammography efficiency and workflow. To create 6mm "SmartSlices," the 3DQuorum technology reconstructs high-resolution 3D data using Genius AI-powered analytics. When reconstructing the SmartSlices, these analytics pinpoint areas of interest that are clinically pertinent and protect crucial features. By limiting the number of images that radiologists must review, SmartSlices shorten read times without sacrificing image sensitivity, accuracy, or quality. The amount of 3D photos to evaluate is decreased by two-thirds with the help of 3DQuorum technology, saving an average of one hour per eight hours of the everyday image interpretation duration.